Kent Miner

Amgen (United States)United States

Immunology and Microbiology · Life Sciences

16h-index1.8kcitations21works0.02yr avg

Accepting Students?

No reports yet. Know if this professor is taking students?


Research Topics

T-cell and B-cell Immunology(11), Immunotherapy and Immune Responses(8), Immune Cell Function and Interaction(8), Asthma and respiratory diseases(3), Protein Kinase Regulation and GTPase Signaling(2)

Publications21 total

Development of an ICOSL and BAFF bispecific inhibitor AMG 570 for systemic lupus erythematosus treatment.
PubMed·2019· 31 cited
Journal of Medicinal Chemistry·2012· 49 citedOpen Access
A novel modality of BAFF-specific inhibitor AMG623 peptibody reduces B-cell number and improves outcomes in murine models of autoimmune disease.
PubMed·2012· 47 cited
Proceedings of the National Academy of Sciences·2000· 572 citedOpen Access
European Journal of Immunology·2000· 5 cited
European Journal of Immunology·2000· 119 citedOpen Access
Lymphotoxin alphabeta is expressed on recently activated naive and Th1-like CD4 cells but is down-regulated by IL-4 during Th2 differentiation.
PubMed·1999· 53 cited
Generation, persistence, and modulation of Th0 effector cells: role of autocrine IL-4 and IFN-gamma.
PubMed·1998· 68 cited
European Journal of Immunology·1998· 96 cited
page 1 of 2Next →

Frequent Co-authors

Michael Croft(10), Sanjay D. Khare(4), Xing-Zhong Xia(4), Hailing Hsu(4), John Whoriskey(4), Irene Gramaglia(4), Helen J. McBride(4), Nessa Hawkins(3), John Delaney(3), T. Boone(3), Robin Elliott(3), Kevin Gaida(3), Deanna Mohn(3), Sean B. Joseph(3), Susan McCabe(2), Irina Solovyev(2), Michael J. Kelley(2), William J. Boyle(2), Frances Lee(2), Gang Yu(2)